Results 131 to 140 of about 827,585 (306)
Clinical Validation of Plasma p‐217tau in Neurological Diseases
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi +13 more
wiley +1 more source
Council on Academic Affairs: Minutes (September 4, 2013)
, 2013 Minutes from the Council on Academic Affairs' meeting on September 4 ...
Ohio State University. Council on Academic Affairs
core
Cracking the Code: Genotype–Phenotype Correlation Models in Sarcoglycanopathies
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Sarcoglycanopathies are among the most severe limb‐girdle muscular dystrophies (LGMD), though milder presentations have been described. These diseases are primarily caused by missense variants, but the limited predictability of their effect on protein maturation, complex formation, and transport has hindered reliable genotype ...
Leonela Luce +72 more
wiley +1 more source
The Council of State in Politics
, 2007 À travers son histoire, le Conseil d’État a toujours exercé une influence politique, contribuant à la diffusion de certaines valeurs ou arbitrant des conflits politiques qui avaient un prolongement contentieux. Dans les années 1980, dans le contexte de l’alternance, on a dénoncé, parfois avec vigueur, la politisation du Conseil d’État. Aujourd’hui, les
openaire +1 more source
Other title: September Council meeting : progress report
, 1944 "September 1944."STATUS OF COUNCIL WORK -- NEW PROPOSALS -- FINAL·ACTION ON PROPOSALS -- Recommendations to the. Legislature -- Revision of the Laws Rel~.ting to Cities -- Psychiatric Facilities -- State Aid for Local Fairs -- Casualty Insurance Rates --
Kansas. Legislature. Legislative Council.
core
Relationship Between Neurologic Symptoms and Signs and FMR1 Genotype in Premutation Carriers
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background and Objectives Fragile X‐associated Tremor/Ataxia Syndrome (FXTAS) is the most severe late‐onset condition caused by a premutation in the FMR1 gene, characterized by expanded CGG triplet repeats of 55–200. Clinical presentations of FXTAS, including gait ataxia, kinetic tremor, cognitive decline, and rare Parkinsonism, are linked to ...
Flora Tassone +8 more
wiley +1 more source
Council on Academic Affairs. Minutes. October 3, 2007
, 2007 This is the minutes for the Council on Academic Affairs' meeting on October 3, 2007. E. Kay Halasek and W. Randy Smith (the Chair and Vice Chair, respectively) gave comments regarding relevant updates. Professors E. Kay Halaske and W.
Ohio State University. Council on Academic Affairs
core
Advancing Age Modulates Associations Between Cognitive Impairment and Brain Volumes in Early MS
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Introduction Cognitive impairment is common in multiple sclerosis (MS), but manifestations following the first demyelinating event are relatively unexplored. We investigated cross‐sectional associations between magnetic resonance imaging (MRI)–derived brain volumes and the presence of cognitive impairment outcomes five years after the first ...
Piriyankan Ananthavarathan +14 more
wiley +1 more source
Other title: March Council meeting, progress report
, 1958 "March 1958."MARCH COUNCIL SESSION -- Status of Council Work -- Legislative Committee on Economy and Efficiency Third Interim Report -- COUNCIL ACTION ON PROPOSALS -- Township Voting - Pro. No.
Kansas. Legislature. Legislative Council.
core
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background X‐linked adrenoleukodystrophy (X‐ALD) is a neurometabolic disorder caused by pathogenic variants in ABCD1, leading to slowly progressive spinal cord disease in nearly all affected men. Sensitive biomarkers to quantify disease severity and predict progression are needed for clinical care and trial design.
Eda G. Kabak +4 more
wiley +1 more source